Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESIST-EXPERIENCED immune tolerance induction with Haemate P in severe hemophilia A with inhibitor after failed prior ITI
NL-OMON35902Phase 4Withdrawn
- Sponsor
- University Medical Center Utrecht
- Start
- Mar 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Haemate P in hemophilia A, sponsored by University Medical Center Utrecht. Primary endpoint: Successful immune tolerance induction. Planned start Mar 2012; status: withdrawn.
02
Drugs
Haemate P
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NL-OMON35902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35902.